“Once-Daily Roflumilast Cream 0.05% for the Treatment of Atopic Dermatitis in Patients Aged 2–5 Years With Diverse Skin Types: Subgroup Analysis From the Phase 3 INTEGUMENT-PED Trial”. SKIN The Journal of Cutaneous Medicine, vol. 10, no. 2, Mar. 2026, p. s745, https://doi.org/10.25251/32bs1796.